U.S CDC Expert Panel: mRNA COVID-19 Vaccines Linked To An Elevated Risk Of Heart Inflammation Issues In Adolescents And Young Adults
Covid Vaccine 'Highly Likely' To Work On UK Variant, Can Adapt It In 6 Weeks To Tackle New Strain If Needed: BioNTech CEO
FDA Finds Moderna Coronavirus Vaccine ‘Highly Effective’, Set To Grant Emergency Use Authorisation On Friday
Moderna To Seek ‘Emergency Use Authorisation’ From US And European Regulators For Covid-19 Vaccine, Efficacy At 94.1%
US-Based Moderna's Covid-19 Vaccine Candidate Shows Positive Results In Older Adults During Trials
A Day After Encouraging Phase I/II Clinical Trial, Pfizer-BioNTech Announces A $1.95 Billion Covid-19 Vaccine Order From U.S. Government
